UNIVERSITY Hospitals of Morecambe Bay NHS Foundation Trust (UHMBT)has called on residents to receive two Covid jabs after administering 128,000 vaccinations against the virus.

UHMBT’s COVID-19 vaccinations have been delivered through three hospital vaccination hubs and three large-scale vaccination centres across Morecambe Bay.

“The light at the end of a very long and dark tunnel”, “hugely inspiring”, “a ray of hope”, “incredibly emotional”, “amazing” and “joyous” is how various members of staff have described the vaccination work.

UHMBT has been working closely with members of the Lancashire Resilience Forum (LRF) and the Cumbria Resilience Forum (CRF) to respond swiftly and effectively to the pandemic. The LRF and CRF are continuing to support the vaccination programme as getting double jabbed as as important as ever to protect the public and the NHS. Second doses of the AstraZeneca, Pfizer and Moderna vaccines all offer the best protection against the virus and work against variants, including the Delta variant.

Lancashire and South Cumbria COVID-19 Vaccination Director, Jane Scattergood, said: “We are now inviting everyone over 18 to bring their second dose appointment forward to eight weeks to ensure everyone has the strongest possible protection as soon as possible.

“The COVID-19 vaccines are two-dose vaccines so you must have both doses for maximum benefit and protection to you, your friends and your family. And to those who have not yet come forward for the vaccine – it is not too late to change your mind. We will continue to make the offer available across all of our vaccination sites and with many offering walk-in appointments, getting your vaccine is easier than ever.”

Almost 8.5 million doses of the COVID-19 vaccine have so far been delivered in the North West since the vaccination programme first started – the largest in NHS history.

As part of this work, teams, individuals and volunteers from across UHMBT have worked tirelessly since December 2020 to vaccinate staff, partner organisations and the public against the virus.

Colleagues at the Trust first started receiving the Pfizer Vaccine in December 2020 and the Oxford Astra Zeneca Vaccine followed in January 2021.